前收市價 | 1.1500 |
開市 | 1.0000 |
買盤 | 0.0000 |
賣出價 | 2.8000 |
拍板 | 10.00 |
到期日 | 2025-01-17 |
今日波幅 | 1.0000 - 1.1500 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 45 |
Voyager Therapeutics (VYGR) delivered earnings and revenue surprises of 54.55% and 88.87%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Agios (AGIO) reports mixed earnings results for first-quarter 2024. Though sales miss the mark, revenues from its sole marketed drug, Pyrukynd, rise sequentially and on a yearly basis.
Jazz's (JAZZ) first-quarter earnings and sales miss the mark. The company reaffirms its guidance for full-year 2024.